The global liquid biopsy market is estimated to reach $1,173.5m in 2019. The kits & reagents submarket holds the biggest share of the global liquid biopsy market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 180-page report you will receive 179 charts– all unavailable elsewhere.
The 180-page report provides clear detailed insight into the liquid biopsy market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Liquid Biopsy Market forecast to 2029
• Revenue forecasts for the Liquid Biopsy Market Forecast by Product to 2029:
• Instruments
• Kits & Reagents
• Services
Each submarket is further segmented by regional market.
• Revenue forecasts for the Liquid Biopsy Market Forecast by Sample to 2029:
• Blood
• Urine
• Other Samples
Each submarket is further segmented by regional market.
• Revenue forecasts for the Liquid Biopsy Market Forecast by Biomarker to 2029:
• Circulating Tumor Cells (CTC)
• Circulating Tumor DNA (CtDNA)
• Exosomes
• Other Biomarkers
Each submarket is further segmented by regional market.
• Revenue forecasts for the Liquid Biopsy Market Forecast by Cancer to 2029:
• Breast Cancer
• Colorectal Cancer
• Liver Cancer
• Lung Cancer
• Prostate Cancer
• Other Cancers
Each submarket is further segmented by regional market.
• Revenue forecasts for the Liquid Biopsy Market Forecast by End-User to 2029:
• Hospitals
• Diagnostic Laboratories
• Academic Institutions
• Cancer Research Centres
Each submarket is further segmented by regional market.
• Revenue forecasts for the Liquid Biopsy Market Forecast by Region to 2029:
North America:
• U.S.
• Canada
• Mexico
Europe:
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia-Pacific:
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific
LAMEA:
• Brazil
• Turkey
• Venezuela
• Saudi Arabia
• Republic of South Africa
• Rest of LAMEA
• Profiles of the selected leading companies:
• Abbott
• Beckman Coulter
• Biocept, Inc.
• Bio-Rad Laboratories
• Biotime
• Caris Lifesciences
• F. Hoffman-La Roche
• Guardant Health, Inc.
• Illumina, Inc.
• MDxHealth SA
• Menarini Silicon Biosystems, Inc.
• Myriad Genetics, Inc.
• OPKO Health, Inc.
• Qiagen N.V.
• Sysmex Inostics
• Trovagene, Inc.
• This report discusses Drivers, Restraints, Opportunities and Threats of the global liquid biopsy market
• The report also includes a PESTLE Analysis of the Global Liquid Biopsy Market
• Key questions answered by this report:
• How is the Liquid Biopsy market evolving?
• What are the drivers and restraints for the growth of the liquid biopsy market?
• What are the market shares of each segment of the overall liquid biopsy market in 2018?
• How will each liquid biopsy submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for each liquid biopsy submarket develop to 2029?
• Which individual therapies will prevail and how will these shifts be responded to?
• What will be the main driver for the overall market to 2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market by 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2019 and 2029?
Visiongain’s study is intended for anyone requiring commercial analyses for the Global Liquid Biopsy Market. You find data, trends and predictions.
Buy our report today Liquid Biopsy Market Forecast : Instruments, Kits and Reagents, Services, Blood Sample, Urine Sample, Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Hospitals, Diagnostic Laboratories, Academic Institutions and Cancer Research Centres.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Liquid Biopsy Market Overview
1.2 Liquid Biopsy Market Definition & Scope
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Key Questions Answered by This Analytical Report
1.6 How This Report Delivers
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Liquid Biopsy Market Overview
2.1 History of Liquid Biopsies
2.2 Advantages of Liquid Biopsies
2.3 Trends in Liquid Biopsy Market
2.3.1 Companies Increasingly Focusing on Developing Biomarkers Detection Kits
2.3.2 Emergence of Oncogenic Mutations Detection Platforms
2.3.3 Rising Demand for Minimally Invasive Cancer Biomarkers Detecting Procedures
2.4 Market Dynamics
2.4.1 Drivers
2.4.1.1 Rising incidence of cancer globally
2.4.1.2 Increasing Rate of Aging Population
2.4.1.3 Rising demand for safe and minimally invasive procedures
2.4.1.4 Advantages of liquid biopsy
2.4.2 Restraints
2.4.2.1 Disparity in reimbursements
2.4.2.2 Strict regulatory environment
2.4.3 Opportunities:
2.4.3.1 Increasing involvement of global market players through collaborations/agreements
2.4.3.2 Progress in the development of liquid biopsy tests
2.5 Global Liquid Biopsy Market: Revenue Forecast, 2018-2029
2.6 Regulatory Landscape for Liquid Biopsies
2.7 Latest developments in the liquid biopsy industry
2.7.1 Emergence of artificial intelligence technologies is set to boost the liquid biopsy market
2.7.2 Liquid biopsy is considered to be one of the most significant breakthrough treatments for cancer
2.7.3 Multi-Target Liquid Biopsy would be a novel clinical test to watch out in 2019
3. Global Liquid Biopsy Market by Product Type: Market Forecast to 2029
3.1 Global Liquid Biopsy Market, By Product Type, Revenue Forecast, 2018-2029
3.2 Instruments Segment
3.2.1 Global Liquid Biopsy Market, Instruments Segment Revenue Forecast, 2018-2029
3.3 Kits & Reagents Segment
3.3.1 Global Liquid Biopsy Market, Kits & Reagents Segment Revenue Forecast, 2018-2029
3.4 Services Segment
3.4.1 Global Liquid Biopsy Market, Services Segment Revenue Forecast, 2018-2029
3.5 Market Share Analysis, by Product Type
4. Global Liquid Biopsy Market by Sample Type: Market Forecast to 2029
4.1 Global Liquid Biopsy Market by Sample Type: Revenue Forecast to 2029
4.2 Global Liquid Biopsy Market: Blood Sample Segment Revenue Forecast to 2029
4.3 Global Liquid Biopsy Market: Urine Sample Segment Revenue Forecast to 2029
4.4 Global Liquid Biopsy Market: Other Samples Revenue Forecast to 2029
4.5 Market Share Analysis by Sample Type
5. Global Liquid Biopsy Market by Biomarker Type: Market Forecast to 2029
5.1 Global Liquid Biopsy Market by Biomarker Type: Revenue Forecast to 2029
5.2 Global Liquid Biopsy Market: Circulating Tumour Cell (CTC) Segment Revenue Forecast to 2029
5.3 Global Liquid Biopsy Market: Circulating Tumour DNA (ctDNA) Segment Revenue Forecast to 2029
5.4 Global Liquid Biopsy Market: Exosomes Segment Revenue Forecast to 2029
5.5 Global Liquid Biopsy Market: Other Biomarkers Segment Revenue Forecast to 2029
5.6 Market Share Analysis by Biomarker Type
6. Global Liquid Biopsy Market by Cancer Type: Market Forecast to 2029
6.1 Global Liquid Biopsy Market by Cancer Type: Revenue Forecast to 2029
6.2 Global Liquid Biopsy Market: Breast Cancer Segment Revenue Forecast to 2029
6.3 Global Liquid Biopsy Market: Colorectal Cancer Segment Revenue Forecast to 2029
6.4 Global Liquid Biopsy Market: Liver Cancer Segment Revenue Forecast to 2029
6.5 Global Liquid Biopsy Market: Lung Cancer Segment Revenue Forecast to 2029
6.6 Global Liquid Biopsy Market: Prostate Cancer Segment Revenue Forecast to 2029
6.7 Global Liquid Biopsy Market: Other Cancers Segment Revenue Forecast to 2029
6.8 Market Share Analysis by Cancer Type
6.9 Comparative Incidence of Cancer by Region
6.9.1 Incidence pattern of breast cancer across geographies
6.9.1.1 Breast cancer incidence in Canada, 2016
7. Global Liquid Biopsy Market by End-User: Market Forecast to 2029
7.1 Global Liquid Biopsy Market by End-User: Revenue Forecast to 2029
7.2 Global Liquid Biopsy Market: Hospitals Segment Revenue Forecast to 2029
7.3 Global Liquid Biopsy Market: Diagnostic Laboratories Segment Revenue Forecast to 2029
7.4 Global Liquid Biopsy Market: Academic Institutions Segment Revenue Forecast to 2029
7.5 Global Liquid Biopsy Market: Cancer Research Centres Segment Revenue Forecast to 2029
7.6 Market Share Analysis by End-User
8. Global Liquid Biopsy Market by Leading Nationals: Market Forecast to 2029
8.1 Global Liquid Biopsy Market by Leading Nationals: Revenue Forecast to 2029
8.2 North America
8.2.1 North America Liquid Biopsy Market: Revenue Forecast to 2029
8.2.2 North America Liquid Biopsy Market: Revenue Forecast by Country to 2029
8.2.3 US Liquid Biopsy Market: Revenue Forecast to 2029
8.2.4 Canada Liquid Biopsy Market: Revenue Forecast to 2029
8.2.5 Mexico Liquid Biopsy Market: Revenue Forecast to 2029
8.3 Europe
8.3.1 Europe Liquid Biopsy Market: Revenue Forecast to 2029
8.3.2 Europe Liquid Biopsy Market: Revenue Forecast by Country to 2029
8.3.3 Germany Liquid Biopsy Market: Revenue Forecast to 2029
8.3.4 France Liquid Biopsy Market: Revenue Forecast to 2029
8.3.5 United Kingdom Liquid Biopsy Market: Revenue Forecast to 2029
8.3.6 Italy Liquid Biopsy Market: Revenue Forecast to 2029
8.3.7 Spain Liquid Biopsy Market: Revenue Forecast to 2029
8.3.8 Russia Liquid Biopsy Market: Revenue Forecast to 2029
8.4 Asia-Pacific
8.4.1 Asia-Pacific Liquid Biopsy Market: Revenue Forecast to 2029
8.4.2 Asia-Pacific Liquid Biopsy Market: Revenue Forecast by Country to 2029
8.4.3 Japan Liquid Biopsy Market: Revenue Forecast to 2029
8.4.4 China Liquid Biopsy Market: Revenue Forecast to 2029
8.4.5 Australia Liquid Biopsy Market: Revenue Forecast to 2029
8.4.6 South Korea Liquid Biopsy Market: Revenue Forecast to 2029
8.4.7 India Liquid Biopsy Market: Revenue Forecast to 2029
8.5 LAMEA
8.5.1 LAMEA Liquid Biopsy Market: Revenue Forecast to 2029
8.5.2 LAMEA Liquid Biopsy Market: Revenue Forecast by Country to 2029
8.5.3 Brazil Liquid Biopsy Market: Revenue Forecast to 2029
8.5.4 Turkey Liquid Biopsy Market: Revenue Forecast to 2029
8.5.5 Venezuela Liquid Biopsy Market: Revenue Forecast to 2029
8.5.6 Saudi Arabia Liquid Biopsy Market: Revenue Forecast to 2029
8.5.7 Republic of South Africa Liquid Biopsy Market: Revenue Forecast to 2029
9. Leading Companies in Liquid Biopsy Market
9.1 Company Ranking: Liquid Biopsy Market
9.2 Menarini Silicon Biosystems, Inc.
9.2.1 Overview
9.2.2 Technology
9.2.3 Products
9.2.4 Recent Strategic Developments
9.3 MDxHealth SA
9.3.1 Overview
9.3.2 Financials
9.3.3 Products
9.3.4 Recent Strategic Developments
9.4 Biocept, Inc.
9.4.1 Overview
9.4.2 Financials
9.4.3 Products
9.4.4 Recent Strategic Developments
9.5 Trovagene, Inc.
9.5.1 Overview
9.5.2 Technology
9.5.3 Financials
9.5.4 Products
9.5.5 Recent Strategic Developments
9.6 Sysmex Inostics GmbH (A Subsidiary of Sysmex Corporation)
9.6.1 Overview
9.6.2 Technology
9.6.3 Products
9.6.4 Financials
9.6.5 Recent Developments
9.7 F. Hoffmann-La Roche AG
9.7.1 Overview
9.7.2 Financials
9.7.3 Products
9.7.4 Recent Strategic Developments
9.8 Bio-Rad Laboratories, Inc.
9.8.1 Overview
9.8.2 Financials
9.8.3 Products
9.8.4 Recent Strategic Developments
9.9 Guardant Health, Inc.
9.9.1 Overview
9.9.2 Products
9.9.3 Recent Strategic Developments
9.10 Illumina, Inc.
9.10.1 Overview
9.10.2 Financials
9.10.3 Recent Strategic Developments
9.11 Myriad Genetics, Inc.
9.11.1 Overview
9.11.2 Financials
9.11.3 Products
9.11.4 Recent Strategic Developments
9.12 Qiagen N.V.
9.12.1 Overview
9.12.2 Financials
9.12.3 Products
9.12.4 Recent Strategic Developments
9.13 Biotime (Oncocyte Corporation)
9.13.1 Overview
9.13.2 Financials
9.13.3 Products
9.14 Abbott
9.14.1 Overview
9.14.2 Financials
9.14.3 Recent Strategic Developments
9.15 Beckman Coulter (Danaher Corporation)
9.15.1 Overview
9.15.2 Financials
9.15.3 Products
9.15.4 Recent Strategic Developments
9.16 Caris Life Sciences
9.16.1 Overview
9.16.2 Products
9.17 OPKO Health, Inc.
9.17.1 Overview
9.17.2 Financials
9.17.3 Products
9.17.4 Recent Strategic Developments
10. Qualitative Analysis of the Liquid Biopsy Market
10.1 PESTEL Analysis of the Liquid Biopsy Market
10.1.1 Political
10.1.1.1 Regulatory Bodies:
10.1.1.2 Insurance / Reimbursement:
10.1.2 Economic
10.1.3 Social
10.1.4 Environmental Factors
10.1.5 Technological
10.1.5.1 Decline in use of Old Technologies and Advent of New Technologies
10.1.5.2 Early Stage Diagnosis of Cancer with Liquid Biopsies
10.1.5.3 Improved Liquid Biopsy Techniques
10.1.5.4 Comparison with Tissue Sampling
10.1.5.5 Cost Reductions and Time Saving with Liquid Biopsies
10.1.6 Legal
10.1.6.1 Regulatory Science Challenge
10.1.6.2 FDA
10.1.6.3 Lawsuits and Litigations
11. Conclusion
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
List of Tables
Table 2.1: Global Liquid Biopsy Market, Revenue ($mn) and AGR (%) 2018-2029
Table 3.1: Global Liquid Biopsy Market, By Product Type, Revenue ($mn), AGR (%) and CAGR (%) 2018-2029
Table 3.2: Global Liquid Biopsy Market, Instruments Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 3.3: Global Liquid Biopsy Instruments Market, Region Segment Revenue ($m), 2017-2029
Table 3.4: Global Liquid Biopsy Market, Kits & Reagents Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2029
Table 3.5: Global Liquid Biopsy Kits & Reagents Market, Region Segment Revenue ($m), 2018-2029
Table 3.6: Global Liquid Biopsy Market, Services Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 3.7: Global Liquid Biopsy Services Market, Region Segment Revenue ($m), 2018-2029
Table 3.8: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Product Type, 2018, 2024, 2029
Table 4.1: Global Liquid Biopsy Market, By Sample Type, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 4.2: Global Liquid Biopsy Market, Blood Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 4.3: Global Liquid Biopsy Blood Sample Market, Region Segment Revenue ($m), 2018-2029
Table 4.4: Global Liquid Biopsy Market, Urine Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 4.5: Global Liquid Biopsy Urine Sample Market, Region Segment Revenue ($m), 2018-2029
Table 4.6: Global Liquid Biopsy Market, Other Samples Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 4.7: Global Liquid Biopsy Other Sample Market, Region Segment Revenue ($m), 2018-2029
Table 4.8: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Sample Type, 2018, 2024, 2029
Table 5.1: Global Liquid Biopsy Market, By Biomarker Type, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 5.2: Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 5.3: Global Liquid Biopsy Circulating Tumour Cell (CTC) Biomarker Market, Region Segment Revenue ($m), 2018-2029
Table 5.4: Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 5.5: Global Liquid Biopsy Circulating Tumour DNA (ctDNA) Biomarker Market, Region Segment Revenue ($m), 2018-2029
Table 5.6: Global Liquid Biopsy Market, Exosomes Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 5.7: Global Liquid Biopsy Exosomes Biomarker Market, Region Segment Revenue ($m), 2018-2029
Table 5.8: Global Liquid Biopsy Market, Other Biomarkers Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 5.9: Global Liquid Biopsy Other Biomarkers Market, Region Segment Revenue ($m), 2018-2029
Table 5.10: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Biomarker Type, 2018, 2024, 2029
Table 6.1: Global Liquid Biopsy Market, By Cancer Type, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 6.2: Global Liquid Biopsy Market, Breast Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 6.3: Global Liquid Biopsy Breast Cancer Market, Region Segment Revenue ($m), 2018-2029
Table 6.4: Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 6.5: Global Liquid Biopsy Colorectal Cancer Market, Region Segment Revenue ($m), 2018-2029
Table 6.6: Global Liquid Biopsy Market, Liver Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 6.7: Global Liquid Biopsy Liver Cancer Market, Region Segment Revenue ($m), 2018-2029
Table 6.8: Global Liquid Biopsy Market, Lung Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 6.9: Global Liquid Biopsy Lung Cancer Market, Region Segment Revenue ($m), 2018-2029
Table 6.10: Global Liquid Biopsy Market, Prostate Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 6.11: Global Liquid Biopsy Prostate Cancer Market, Region Segment Revenue ($m), 2018-2029
Table 6.12: Global Liquid Biopsy Market, Other Cancers Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 6.13: Global Liquid Biopsy Other Cancer Market, Region Segment Revenue ($m), 2018-2029
Table 6.14: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Cancer Type, 2018, 2024, 2029
Table 7.1: Global Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 7.2: Global Liquid Biopsy Market, Hospitals Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 7.3: Global Liquid Biopsy Hospitals Market, Region Segment Revenue ($m), 2018-2029
Table 7.4: Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 7.5: Global Liquid Biopsy Diagnostic Laboratories Market, Region Segment Revenue ($m), 2018-2029
Table 7.6: Global Liquid Biopsy Market, Academic Institutions Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 7.7: Global Liquid Biopsy Academic Institutions Market, Region Segment Revenue ($m), 2018-2029
Table 7.8: Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 7.9: Global Liquid Biopsy Cancer Research Centres Market, Region Segment Revenue ($m), 2018-2029
Table 7.10: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by End User, 2018, 2024, 2029
Table 8.1: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Leading Nationals, 2018, 2024, 2029
Table 8.2: Global Liquid Biopsy Market, By Leading Nationals, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.3: North America Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.4: North America Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2018-2029
Table 8.5: US Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.6: Canada Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.7: Mexico Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.8: Europe Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.9: Europe Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028
Table 8.10: Germany Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.11: France Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.12: United Kingdom Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.13: Italy Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.14: Spain Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.15: Russia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.16: Asia-Pacific Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.17: Asia-Pacific Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2018-2029
Table 8.18: Japan Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.19: China Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.20: Australia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.21: South Korea Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.22: India Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.23: LAMEA Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.24: LAMEA Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2018-2029
Table 8.25: Brazil Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.26: Turkey Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 8.27: Venezuela Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.28: Saudi Arabia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 8.29: Republic of South Africa Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2018-2029
Table 9.1: Silicon Biosystems Product Portfolio
Table 9.2: Silicon Biosystems Recent Developments
Table 9.3: MDxHealth SA Financials ($m), 2015-2017
Table 9.4: MDxHealth SA Product Portfolio
Table 9.5: MDxHealth SA Recent Developments
Table 9.6: Biocept Financials ($thousand), 2014-2016
Table 9.7: Biocept Product Portfolio
Table 9.8: Biocept Recent Developments
Table 9.9: Trovagene, Inc. Financials ($thousand), 2015-2017
Table 9.10: Trovagene, Inc. Product Portfolio
Table 9.11: Trovagene, Inc. Recent Developments
Table 9.12: Sysmex Inostics Product Portfolio
Table 9.13: Sysmex Inostics Financials ($m), 2015-2017
Table 9.14: Sysmex Inostics GmbH Recent Developments
Table 9.15: Roche Financials ($m), 2015-2017
Table 9.16: Roche Product Portfolio
Table 9.17: Roche Recent Developments
Table 9.18: Bio-Rad Financials ($m), 2014-2016
Table 9.19: Bio-Rad Product Portfolio
Table 9.20: Bio-Rad Recent Developments
Table 9.21: Guardant Product Portfolio
Table 9.22: Guardant Recent Developments
Table 9.23: Illumina Financials ($m), 2014-2016
Table 9.24: Illumina (GRAIL) Recent Developments
Table 9.25: Myriad Financials ($m), 2015-2017
Table 9.26: Myriad Product Portfolio
Table 9.27: Myriad Recent Developments
Table 9.28: Qiagen Financials ($m), 2015-2017
Table 9.29: Qiagen Product Portfolio
Table 9.30: Qiagen Recent Developments
Table 9.31: Biotime (Oncocyte Corporation) Financials ($m), 2015-2017
Table 9.32: Biotime (Oncocyte Corporation) Product Portfolio
Table 9.33: Abbott Financials ($m), 2015-2017
Table 9.34: Abbott Recent Developments
Table 9.35: Beckman Coulter (Danaher Corporation) Financials ($m), 2015-2017
Table 9.36: Beckman Coulter Product Portfolio
Table 9.37: Beckman Coulter Recent Developments
Table 9.38: Caris Life Sciences Product Portfolio
Table 9.39: OPKO Health, Inc. Financials ($m), 2015-2017
Table 9.40: OPKO Health, Inc. Product Portfolio
Table 9.41: OPKO Health, Inc. Recent Developments
List of Figures
Figure 2.1 Ageing Population Estimates 2010 – 2050
Figure 2.2: Global Liquid Biopsy Market Revenue ($mn), 2018-2029
Figure 2.3: Latest trends in liquid biopsy
Figure 3.1: Global Liquid Biopsy Market Revenue ($m), By Product Type, 2018-2029
Figure 3.2: Global Liquid Biopsy Market, Instruments Segment Revenue ($m), 2018-2029
Figure 3.3: Global Liquid Biopsy Market, Kits & Reagents Segment Revenue ($m), 2018-2029
Figure 3.4: Global Liquid Biopsy Market, Services Segment Revenue ($m), 2018-2029
Figure 4.1: Global Liquid Biopsy Market Revenue ($m), By Sample Type, 2017-2029
Figure 4.2: Global Liquid Biopsy Market, Blood Sample Segment Revenue ($m), 2018-2029
Figure 4.3: Global Liquid Biopsy Market, Urine Sample Segment Revenue ($m), 2018-2029
Figure 4.4: Global Liquid Biopsy Market, Other Samples Segment Revenue ($m), 2018-2029
Figure 5.1: Global Liquid Biopsy Market Revenue ($m), By Biomarker Type, 2018-2029
Figure 5.2: Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue ($m), 2018-2029
Figure 5.3: Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue ($m), 2018-2029
Figure 5.4: Global Liquid Biopsy Market, Exosomes Segment Revenue ($m), 2018-2029
Figure 5.5: Global Liquid Biopsy Market, Other Biomarkers Segment Revenue ($m), 2018-2029
Figure 6.1: Global Liquid Biopsy Market Revenue ($m), By Cancer Type, 2018-2029
Figure 6.2: Global Liquid Biopsy Market, Breast Cancer Segment Revenue ($m), 2018-2029
Figure 6.3: Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue ($m), 2018-2029
Figure 6.4: Global Liquid Biopsy Market, Liver Cancer Segment Revenue ($m), 2018-2029
Figure 6.5: Global Liquid Biopsy Market, Lung Cancer Segment Revenue ($m), 2018-2029
Figure 6.6: Global Liquid Biopsy Market, Prostate Cancer Segment Revenue ($m), 2018-2029
Figure 6.7: Global Liquid Biopsy Market, Other Cancers Segment Revenue ($m), 2018-2029
Figure 6.8: Cancer Mortalities Across Geographies, 2018
Figure 6.9: Cancer Incidence Across Geographies, 2018
Figure 6.10: Cancer Incidence vs Mortality Scenario Across Geographies, 2018
Figure 6.11: New cases of breast cancer at different age groups, 2015
Figure 6.12: New cases of breast cancer at different age groups, 2016
Figure 7.1: Global Liquid Biopsy Market Revenue ($m), By End User, 2018-2029
Figure 7.2: Global Liquid Biopsy Market, Hospitals Segment Revenue ($m), 2018-2029
Figure 7.3: Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue ($m), 2018-2029
Figure 7.4: Global Liquid Biopsy Market, Academic Institutions Segment Revenue ($m), 2018-2029
Figure 7.5: Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue ($m), 2018-2029
Figure 8.1: Global Liquid Biopsy Market Revenue ($m), by Leading Nationals, 2018-2029
Figure 8.2: North America Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.3: US Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.4: Canada Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.5: Mexico Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.6: Europe Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.7: Germany Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.8: France Liquid Biopsy Market, Revenue ($m), 2017-2029
Figure 8.9: United Kingdom Liquid Biopsy Market, Revenue ($m), 2017-2029
Figure 8.10: Italy Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.11: Spain Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.12: Russia Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.13: Asia-Pacific Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.14: Japan Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.15: China Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.16: Australia Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.17: South Korea Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.18: India Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.19: LAMEA Liquid Biopsy Market, Revenue ($m), 2017-2028
Figure 8.20: Brazil Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.21: Turkey Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.22: Venezuela Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.23: Saudi Arabia Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 8.24: Republic of South Africa Liquid Biopsy Market, Revenue ($m), 2018-2029
Figure 9.1 Top Companies in Liquid Biopsy Market
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
